In vitro and in vivo evaluation of WAC-224, a novel quinolone class of topoisomerase II inhibitor for cancer therapy

被引：0
|
作者：
Ueshima, Taichi
Yamaguchi, Tomonori
Itoh, Kenji
Kashimoto, Naoki
Hirano, Tatsuya
Shimabara, Rumiko
Kawakubo, Yohei
Sato, Masayuki
Yamashita, Junpei
Yazaki, Akira
Tamura, Koichi
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5106
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A nanoformulation of siRNA and its role in cancer therapy: In vitro and in vivo evaluation
    Jagani, Hitesh
    Rao, Josyula Venkata
    Palanimuthu, Vasanth Raj
    Hariharapura, Raghu Chandrashekar
    Gang, Sagar
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2013, 18 (01) : 120 - 136
  • [32] A nanoformulation of siRNA and its role in cancer therapy: In vitro and in vivo evaluation
    Hitesh Jagani
    Josyula Venkata Rao
    Vasanth Raj Palanimuthu
    Raghu Chandrashekar Hariharapura
    Sagar Gang
    Cellular & Molecular Biology Letters, 2013, 18 : 120 - 136
  • [33] Evaluation of in vitro and in vivo antibacterial activity of novel Cu(II)-steroid complexes
    Barrett, Stephen
    Delaney, Stephen
    Kavanagh, Kevin
    Montagner, Diego
    INORGANICA CHIMICA ACTA, 2018, 479 : 261 - 265
  • [34] In vitro and in vivo evaluation of the toxicological and molecular effects of a novel Pd(II) complex
    Adiguzel, Zelal
    Baykal, Tank
    Cetin, Yuksel
    Kacar, Omer
    Serhatli, Muge
    Polat, Hivda
    Ulukaya, Engin
    Yilmaz, Veysel T.
    Acilan, Ceyda
    TOXICOLOGY LETTERS, 2013, 221 : S73 - S74
  • [35] Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo
    Liu, Xinyu
    Li, Wenjing
    Xu, Licheng
    Chen, Xiaoxue
    Zhao, Rui
    Guo, Yan
    Ge, Jingchun
    Yang, Zhenming
    Li, Liang
    Zhang, Jiarui
    Cao, Jing
    Shao, Yue
    Guo, Xinyue
    Tian, Linli
    Liu, Ming
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2023, 158
  • [36] The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo
    Okada, Masashi
    Suzuki, Shuhei
    Seino, Manabu
    Takeda, Hiroyuki
    Kitanaka, Chifumi
    CANCER SCIENCE, 2018, 109 : 269 - 269
  • [37] The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo
    Okada, Masashi
    Kuramoto, Kenta
    Takeda, Hiroyuki
    Watarai, Hikaru
    Sakaki, Hirotsugu
    Seino, Shizuka
    Seino, Manabu
    Suzuki, Shuhei
    Kitanaka, Chifumi
    ONCOTARGET, 2016, 7 (19) : 27021 - 27032
  • [38] CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo
    Tse, Archie N.
    Rendahl, Katherine G.
    Sheikh, Tahir
    Cheema, Haider
    Aardalen, Kim
    Embry, Millicent
    Ma, Sylvia
    Moler, Edward J.
    Ni, Zhi Jie
    de Menezes, Daniel E. Lopes
    Hibner, Barbara
    Gesner, Thomas G.
    Schwartz, Gary K.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 591 - 602
  • [39] The Novel Dual Topoisomerase Inhibitor P8-D6 Shows Anti-myeloma Activity In Vitro and In Vivo
    Klausz, Katja
    Kellner, Christian
    Gehlert, Carina Lynn
    Krohn, Steffen
    Wilcken, Hauke
    Floerkemeier, Inken
    Guenther, Andreas
    Bauerschlag, Dirk O.
    Clement, Bernd
    Gramatzki, Martin
    Peipp, Matthias
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (01) : 70 - 78
  • [40] In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase
    Tan, Christopher M.
    Gill, Charles J.
    Wu, Jin
    Toussaint, Nathalie
    Yin, Jingjun
    Tsuchiya, Takayuki
    Garlisi, Charles G.
    Kaelin, David
    Meinke, Peter T.
    Miesel, Lynn
    Olsen, David B.
    Lagrutta, Armando
    Fukuda, Hideyuki
    Kishii, Ryuta
    Takei, Masaya
    Oohata, Kouhei
    Takeuchi, Tomoko
    Shibue, Taku
    Takano, Hisashi
    Nishimura, Akinori
    Fukuda, Yasumichi
    Singh, Sheo B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (08) : 4830 - 4839
12345